Omega Fund IV G.P. Manager, Ltd.

CIK 1624456 · last filed 2022-03-16

Omega Fund IV G.P. Manager, Ltd. is a corporate insider who has filed 9 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing, for REPL, was dated Mar 16, 2022. Across all open-market trades the lifetime net is −$6.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $142.5M across reported positions. The firm reports its address in Boston, MA. 25 SEC filings were submitted jointly with Omega Fund IV GP, L.P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$142.51M

Companies

3

Total Filings

9

Lifetime Open-Market Net

-$5.98M

Filer Profile

Reported Address

888 BOYLSTON ST., SUITE 1111
BOSTON, MA 02199

Phone

(617) 502-6538

State of Incorporation

Cayman Islands

Related Filers

Omega Fund IV GP, L.P. — 25 joint filings, latest 2022-03-16

Omega Fund IV, L.P. — 25 joint filings, latest 2022-03-16

Otello Stampacchia — 25 joint filings, latest 2022-03-16

Anne-Mari Paster — 9 joint filings, latest 2021-04-05

Richard J. Lim — 7 joint filings, latest 2019-04-03

Claudio Nessi — 2 joint filings, latest 2018-07-03

Omega Fund V GP Manager, Ltd. — 2 joint filings, latest 2018-07-03

Omega Fund V GP, L.P. — 2 joint filings, latest 2018-07-03

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
REPL	10%+ Owner	9,475,522	$15.04	$142.51M	-$5.98M	7	2022-03-16
Translate Bio, Inc. (TBIO) Delisted	10%+ Owner	135,423	$0.00	$14	$0	1	2018-07-03
Kezar Life Sciences, Inc. (KZR) Delisted		100,876	$7.29	$735.4K	$0	1	2018-06-25

Recent Filings

9 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2022-03-16	REPL	Mixed	−360,000	-$5.98M	EDGAR
2021-11-23	REPL	Sell (S)	−181,696	-$6.28M	EDGAR
2021-11-18	REPL	Sell (S)	−10,376	-$347.6K	EDGAR
2021-09-20	REPL	Sell (S)	−400,000	-$13.20M	EDGAR
2021-04-05	REPL	Grant (A)	—	$0	EDGAR
2021-01-19	REPL	Sell (S)	−78,320	-$3.53M	EDGAR
2018-07-25	REPL	Mixed	+29,128,698	$24.00M	EDGAR
2018-07-03	Translate Bio, Inc. (TBIO) Delisted	Conv (C)	+48,752,060	$0	EDGAR
2018-06-25	Kezar Life Sciences, Inc. (KZR) Delisted	Conv (C)	+8,319,264	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.